Bernd Schnabl

31.1k total citations · 13 hit papers
217 papers, 18.0k citations indexed

About

Bernd Schnabl is a scholar working on Epidemiology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Bernd Schnabl has authored 217 papers receiving a total of 18.0k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Epidemiology, 108 papers in Molecular Biology and 70 papers in Pathology and Forensic Medicine. Recurrent topics in Bernd Schnabl's work include Liver Disease Diagnosis and Treatment (147 papers), Gut microbiota and health (83 papers) and Alcohol Consumption and Health Effects (70 papers). Bernd Schnabl is often cited by papers focused on Liver Disease Diagnosis and Treatment (147 papers), Gut microbiota and health (83 papers) and Alcohol Consumption and Health Effects (70 papers). Bernd Schnabl collaborates with scholars based in United States, Germany and Belgium. Bernd Schnabl's co-authors include David A. Brenner, Ekihiro Seki, Peter Stärkel, Phillipp Hartmann, Rohit Loomba, Katharina Brandl, Rob Knight, Derrick E. Fouts, Michael Karin and Yi Duan and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Bernd Schnabl

212 papers receiving 17.9k citations

Hit Papers

The gut–liver axis and th... 2008 2026 2014 2020 2018 2018 2014 2010 2010 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The gut–liver axis and the intersection with the microbiome
    2018 1.0k citations David A. Brenner, Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology profile →
  2. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation
    2018 881 citations Bernd Schnabl, Tatiana Kisseleva et al. profile →
  3. Interactions Between the Intestinal Microbiome and Liver Diseases
    2014 743 citations Bernd Schnabl, David A. Brenner profile →
  4. Enteric dysbiosis associated with a mouse model of alcoholic liver disease
    2010 639 citations Derrick E. Fouts, Peter Stärkel et al. Hepatology profile →
  5. Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
    2010 615 citations Bernd Schnabl, David A. Brenner et al. profile →
  6. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
    2008 508 citations Katharina Brandl, Bernd Schnabl et al. profile →
  7. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis
    2015 409 citations Bernd Schnabl et al. Journal of Hepatology profile →
  8. FXR Regulates Intestinal Cancer Stem Cell Proliferation
    2019 331 citations Bernd Schnabl, Ruth T. Yu et al. profile →
  9. The gut–liver axis and gut microbiota in health and liver disease
    2023 322 citations Bernd Schnabl et al. profile →
  10. Gut microbiome, liver immunology, and liver diseases
    2020 303 citations Bernd Schnabl et al. profile →
  11. Acute-on-chronic liver failure in cirrhosis
    2016 295 citations Bernd Schnabl et al. profile →
  12. The microbiota in cirrhosis and its role in hepatic decompensation
    2021 143 citations Jonel Trebicka, Bernd Schnabl et al. Journal of Hepatology profile →
  13. Metabolic dysfunction–associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations
    2025 25 citations Bernd Schnabl et al. Journal of Clinical Investigation profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Bernd Schnabl 9.0k 9.0k 3.9k 3.1k 2.8k 217 18.0k
Samuel W. French 8.4k 0.9× 7.6k 0.9× 2.5k 0.6× 1.8k 0.6× 5.6k 2.0× 574 22.4k
Hiroshi Fukui 4.9k 0.5× 6.1k 0.7× 3.7k 0.9× 2.0k 0.6× 1.5k 0.5× 324 15.1k
Gyöngyi Szabó 12.6k 1.4× 9.1k 1.0× 5.9k 1.5× 1.6k 0.5× 7.1k 2.5× 314 26.0k
Ariel E. Feldstein 17.2k 1.9× 9.2k 1.0× 6.3k 1.6× 4.2k 1.4× 2.2k 0.8× 220 26.9k
Alexander R. Moschen 7.6k 0.8× 4.8k 0.5× 1.4k 0.3× 3.6k 1.2× 1.1k 0.4× 122 15.2k
Ekihiro Seki 9.4k 1.0× 6.2k 0.7× 6.2k 1.6× 1.3k 0.4× 1.5k 0.6× 140 18.5k
Robert F. Schwabe 10.4k 1.2× 8.7k 1.0× 8.5k 2.2× 1.5k 0.5× 1.6k 0.6× 130 24.3k
Reiner Wiest 5.4k 0.6× 4.9k 0.5× 4.2k 1.1× 2.3k 0.8× 642 0.2× 104 12.2k
Phillip B. Hylemon 6.2k 0.7× 10.4k 1.2× 2.8k 0.7× 2.8k 0.9× 858 0.3× 241 19.7k
Fabio Marra 10.4k 1.2× 3.7k 0.4× 8.1k 2.0× 1.2k 0.4× 1.1k 0.4× 280 17.9k

Countries citing papers authored by Bernd Schnabl

Since Specialization
Citations

This map shows the geographic impact of Bernd Schnabl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Schnabl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Schnabl more than expected).

Fields of papers citing papers by Bernd Schnabl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd Schnabl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Schnabl. The network helps show where Bernd Schnabl may publish in the future.

Co-authorship network of co-authors of Bernd Schnabl

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd Schnabl. A scholar is included among the top collaborators of Bernd Schnabl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd Schnabl. Bernd Schnabl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cabré, Noemí, Marcos F. Fondevila, Tomoo Yamazaki, et al.. (2025). Activation of intestinal endogenous retroviruses by alcohol exacerbates liver disease. Journal of Clinical Investigation. 135(13). 3 indexed citations
2.
Hu, Yifan, Bernd Schnabl, & Peter Stärkel. (2025). Origin, Function, and Implications of Intestinal and Hepatic Macrophages in the Pathogenesis of Alcohol-Associated Liver Disease. Cells. 14(3). 207–207. 1 indexed citations
3.
Yang, Yongqiang & Bernd Schnabl. (2024). Gut Bacteria in Alcohol-Associated Liver Disease. Clinics in Liver Disease. 28(4). 663–679. 7 indexed citations
4.
Meijnikman, Abraham S., Max Nieuwdorp, & Bernd Schnabl. (2024). Endogenous ethanol production in health and disease. Nature Reviews Gastroenterology & Hepatology. 21(8). 556–571. 22 indexed citations
5.
Burra, Patrizia, Alberto Zanetto, Bernd Schnabl, et al.. (2024). Hepatic immune regulation and sex disparities. Nature Reviews Gastroenterology & Hepatology. 21(12). 869–884. 12 indexed citations
6.
Meijnikman, Abraham S., Marcos F. Fondevila, Marco Arrese, et al.. (2024). Towards more consistent models and consensual terminology in preclinical research for steatotic liver disease. Journal of Hepatology. 82(4). 760–766. 1 indexed citations
7.
Llorente, Cristina, Shengyun Ma, K. Miyamoto, et al.. (2023). The arginine methyltransferase PRMT5 promotes mucosal defense in the intestine. Life Science Alliance. 6(11). e202302026–e202302026. 4 indexed citations
8.
Hartmann, Phillipp, Sonja Lang, Robert Schierwagen, et al.. (2023). Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure. Hepatobiliary & pancreatic diseases international. 22(5). 474–481. 7 indexed citations
9.
Zeng, Su-Ling, Yanhan Wang, Yi Duan, et al.. (2023). Engineered bacteria producing aryl‐hydrocarbon receptor agonists protect against ethanol‐induced liver disease in mice. Alcohol Clinical and Experimental Research. 47(5). 856–867. 27 indexed citations
10.
Özdirik, Burcin & Bernd Schnabl. (2023). Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts. Cellular and Molecular Gastroenterology and Hepatology. 17(3). 423–438. 11 indexed citations
11.
Cabré, Noemí, Phillipp Hartmann, Cristina Llorente, et al.. (2023). IgY antibodies against cytolysin reduce ethanol-induced liver disease in mice. Hepatology. 78(1). 295–306. 10 indexed citations
12.
Mendes, Beatriz Garcia, Yi Duan, & Bernd Schnabl. (2022). Immune Response of an Oral Enterococcus faecalis Phage Cocktail in a Mouse Model of Ethanol-Induced Liver Disease. Viruses. 14(3). 490–490. 13 indexed citations
13.
Philips, Cyriac Abby, Bernd Schnabl, & Jasmohan S. Bajaj. (2022). Gut Microbiome and Alcohol-associated Liver Disease. Journal of Clinical and Experimental Hepatology. 12(5). 1349–1359. 20 indexed citations
14.
Hartmann, Phillipp, Yi Duan, Yukiko Miyamoto, et al.. (2022). Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice. Hepatology International. 16(2). 359–370. 22 indexed citations
15.
Gao, Bei, Liang Chi, Yixin Zhu, et al.. (2021). An Introduction to Next Generation Sequencing Bioinformatic Analysis in Gut Microbiome Studies. Biomolecules. 11(4). 530–530. 116 indexed citations
16.
Duan, Yi, Ry Young, & Bernd Schnabl. (2021). Bacteriophages and their potential for treatment of gastrointestinal diseases. Nature Reviews Gastroenterology & Hepatology. 19(2). 135–144. 86 indexed citations
17.
Lang, Sonja, Münevver Demir, Yi Duan, Anna Martin, & Bernd Schnabl. (2020). Cytolysin‐positive Enterococcus faecalis is not increased in patients with non‐alcoholic steatohepatitis. Liver International. 40(4). 860–865. 32 indexed citations
18.
Jiang, Lu, Huikuan Chu, Bei Gao, et al.. (2020). Transcriptomic Profiling Identifies Novel Hepatic and Intestinal Genes Following Chronic Plus Binge Ethanol Feeding in Mice. Digestive Diseases and Sciences. 65(12). 3592–3604. 15 indexed citations
19.
Wang, Lirui, Magdalena Mazagova, Chuyue Pan, et al.. (2019). YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity. Proceedings of the National Academy of Sciences. 116(30). 15184–15193. 29 indexed citations
20.
Siggs, Owen M., Bernd Schnabl, Bill D. Webb, & Bruce Beutler. (2011). X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C. Proceedings of the National Academy of Sciences. 108(19). 7890–7895. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel W. French Breakdown of academic impact, for papers by Hiroshi Fukui Breakdown of academic impact, for papers by Gyöngyi Szabó Breakdown of academic impact, for papers by Ariel E. Feldstein Breakdown of academic impact, for papers by Alexander R. Moschen Breakdown of academic impact, for papers by Ekihiro Seki Breakdown of academic impact, for papers by Robert F. Schwabe Breakdown of academic impact, for papers by Reiner Wiest Breakdown of academic impact, for papers by Phillip B. Hylemon Breakdown of academic impact, for papers by Fabio Marra
Rankless by CCL
2026